Biotech componentsPlant

Products 41 to 50 of 120

Encapso by Solazyme + Encapso
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Middle East + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/04/01 16:30 (5 years ago)
Known funding amount: 174,900,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: SZYM (NASDAQ)
Value chain stage: Finished Product
Endocannabinoids for intestinal infection treatment by University of Texas Southwestern Medical Center
Biotech components: Molecule + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 years ago)
Date last modified: 2020/12/18 14:39 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
EveNootkatone by Evolva
Biotech components: Plant
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 909,000 USD
Funding types: Crowdfunding + Private Funding
Industry: Novelty
Market status: No longer on the market
Organization type(s): Private Company
Product categories: Plant
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
EverSweet™ by Evolva + Cargill
Biotech components: Plant
Business models: B2B + B2C
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/13 15:54 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 909,000 USD
Funding types: Crowdfunding + Private Funding
Industry: Food & Agriculture
Market status: No longer on the market
Organization type(s): Private Company
Product categories: Plant
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 909,000 USD
Funding types: Crowdfunding + Private Funding
Industry: Food & Agriculture
Market status: No longer on the market
Organization type(s): Private Company
Product categories: Plant
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/28 16:45 (5 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:47 (5 years ago)
Date last modified: 2019/09/12 14:47 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Novelty
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/02 11:41 (5 years ago)
Known funding amount: 909,000 USD
Funding types: Crowdfunding + Private Funding
Industry: Health
Market status: No longer on the market
Organization type(s): Private Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product